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GISA (Glycopeptide-lntermediate Staphylococcus 
aureus) Selected by Vancomycin Treatment 
of Experimental Endocarditis Persist after 
Treatment Arrest In Vivo, but are not Detected 
by Vegetation Cultures In Vitro 
J.M. Entenza*, J. Vouillamoz, M. Giddey, 
P. Moreillon. Department o[ Fundamental 
Microbiology BB - University o[ Lausanne, 
CH- 1015 Lausanne, Switzerland 
Background: Laboratory diagnosis of glycopeptide- 
intermediate Staphylococcus aureus (GISA) and 
their heterogeneous-GISA (h-GISA) precursors is 
difficult. Thus, it is possible that vancomycin fail- 
ures against supposedly vancomycin-susceptible 
S. aureus are in fact due to GISA or h-GISA. 
We tested this hypothesis during vancomycin 
treatment of experimental endocarditis due 
to a vancomycin-susceptible, methicillin-resistant 
S. aureus (MRSA). 
Methods: Rats with aortic experimental endocardi- 
tis due to the vancomycin-susceptible MRSA M1 
were treated with human-like kinetics of van- 
comycin (1 g i.v. every 12 h). Treatment was started 
16 h after bacteria[ challenge and given for 2 days. 
Groups were killed either at the start of ther- 
apy, 8h or 3 days after treatment arrest. Pop- 
ulation analysis was done directly on vegetation 
homogenates, or after 1 subculture in drug-free 
medium to mimic standard diagnostic procedures. 
Results: The vancomycin-susceptible parent had an 
MIC of vancomycin of 2 mg/l, and grew on <4 mg/l 
in population analysis. Eight hours after treatment 
arrest, 6/13 rats had still positive valve cultures, 
one of which was harboring an h-GISA (growing 
on 8 mg/l of vancomycin in population analysis). 
Three days after treatment arrest, 6/13 rats had 
positive valve cultures, all of which was harboring 
h-GISA (growing on 8 mg/l of vancomycin). In con- 
trast, 1 single subculture of vegetations in drug- 
free broth was enough to revert all the h-GISA to 
the susceptible pattern of the parent. 
Conclusions: Vancomycin selected for h-GISA dur- 
ing therapy of experimental endocarditis due to 
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vancomycin-susceptible S. aureus. These h-GISA 
were associated with vancomycin failure. The 
h-GISA phenotype persisted in vivo even after ar- 
rest of vancomycin. On the other hand, the h-GISA 
phenotype was missed in vitro after a single pas- 
sage on drug-free medium. Thus, h-GISA escape de- 
tection in clinical samples if they are subcultured 
before susceptibility tests. 
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Age Limits do not Replace Serologic Tests for 
Immune Status Against Measles 
I. U~:kay*, S. Hugonnet, N. Bessire, L. Kaiser, 
C.A. Siegrist, D. Pittet. Division o[ In[ectious 
Diseases Geneva University Hospitals, Geneva, 
Switzerland 
Background: Measles are a highly contagious and 
preventable childhood infection. Disease may be 
severe in adults and a single dose of vaccine pro- 
tects only to 90%. Because of a herd immunity 
(max. 85% vaccine coverage, seroprevalence <95%) 
epidemics regularly occur in Switzerland and in 
other countries. According to common belief and 
federal recommendations, persons over 40 years 
of age are considered immune due to childhood 
exposure before vaccine availabNty since 1964. We 
questioned this presumption by a mass serologic 
screening in the University HosNta[s of Geneva. 
Methods: In January 2005 4 Health Care Workers 
(HCW) were victim of a nosocomial outbreak and 
35 other persons (8 adults and 27 adolescents) 
developed measles in the community. By fear of 
a large epidemic and lack of knowledge of the 
immunity status of HCWs, a mass screening and/or 
vaccination campaign was started. The serologic 
exams were made by XXX. 
Results: 117 of 2600 adult HCWs and patients 
were seronegative for measles (4.5%). 31 seroneg- 
ative persons were older than 40 years (26% of all 
seronegative adults), the oldest being a 76 years 
old HCW. 13 HCWs were immunocompetent and 
1 HCW had smoldering myeloma. Among 7 patients 
had transplantation (TPL): 2 bone marrow TPL, 
4 renal TPL and 1 cardiac TPL, 1 had cirrhosis and 
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1 had AIDS. No testing of cettutar immunity was 
performed. 
Conclusion: Age timits do not reptace the serotogic 
immune status of adutts for meastes. Up to a quar- 
ter of adutts more than 40 years may be seroneg- 
ative. Untess cettutar immunity is not protecting 
from acquiring this highty contagious disease, these 
persons profited so far from the herd immunity in 
the society. 
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Postsinusitis Staphylococcal Pituitary Abscess 
I. U~:kay*, C. Garzoni, V. Nobre, J.L. Barrios. 
Division des Maladies Infectieuses HOpitaux 
Universitaires de Geneve, Geneva, Switzerland 
Objective: Singte pituitary abscesses are in itseff 
rare. A postsinusitis pituitary abscess by Staphy- 
lococcus aureus is a rarity too, since the germ is 
frequentty found in non-operative sinusitis. 
Case report: A 71 year otd heatthy man had been 
treated for frontat community-acquired sinusitis 
with cefutoxime during five days with consequent 
ctinicat ametioration but persistence of fatigue. 
Endocrinotogicat exams reveated a panhypopitu- 
itarism. IRM examination of the settar region 
showed a tumorat mass of 14xgxl 1 mm size. There 
was no other suspect region either in radiotogicat 
or in ctinicat examinations. Neurosurgicat excision 
was performed in suspicion of a neoptasia, but the 
surgeons found franc pus. The cutture identified 
methicittin-sensitive S. aureus (MSSA). Antibiotic 
treatment with intravenous Ftuctoxacittin 6 x 2 g/d 
during six weeks was successful 
Conclusion: Pituitary abscesses by MSSA and ctini- 
cat [ate onset abscesses after "bahai" episodes of 
sinusitis do exist (even by MSSA) and are difficutt to 
be diagnosed. Literature is spearse. To our knowt- 
edge this woutd be the second case of S. aureus 
described in the titerature. Further studies are 
needed to access the prevatence of this underre- 
ported, unusuat, non-bacteremic origin in retation 
to ctassicat postoperative abscesses by S. aureus. 
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Leishmaniasis in Immunocompromised Patients: 
Shift in Risk Factors from HIV to Other 
Immunosuppressive Conditions. Retrospective 
Analysis of 12 Cases and Review of the 
Literature 
M. Weisser 1 *, B. Khantari 2, L. Terracciano 3, 
C. Arber 4, A. Gratwoht 4, S. Bassettg, M. Battegay ~ ,
U. Ftuckiger ~. 1Division of Infectious Diseases Et 
Hospital Epidemiolog~ University Hospital 
Basel, Switzerland, 2Department of Internal 
Medicine, University Hospital Basel, Switzerland, 
3Department of Pathology, University Hospital 
Basel, Switzerland, 4Division of Hematology, 
University Hospital Basel, Switzerland 
Introduction: Leishmaniasis is a rare disease in 
Western Europe. Migration can read to emergence 
of cases in non-endemic regions. Undertying im- 
munosuppression is a risk factor for severe course 
of infection. We were interested in frequency of 
disease in our area and risk factors for devetoping 
symptomatic disease. 
Materials ~ Methods: We retrospectivety anatyzed 
art cases of teishmaniasis diagnosed and/or treated 
in our hospitat and searched charts for undertying 
diseases and epidemiotogy. 
Results: From 1990 to 2005 we found 12 cases 
diagnosed with teishmaniasis. 8 patients were di- 
agnosed and treated in our hospitat, 4 patients 
were treated in other hospitats situated nearby. 
The diagnosis of infection with teishmania spp was 
confirmed histotogicatty in 11 patients. In 1 patient 
onty a serotogy was done to confirm diagnosis. 
Potymerase chain reaction with identification of 
the teishmaniat strain was avaitabte in 6 cases. 
7 patients were originatty from a country with 
endemic teishmaniasis (5 from Itaty, 1 from Por- 
tugat and 1 from Turkey). 5 patients were Swiss 
and acquired disease during vacation in endemic 
countries (1 to South America, 3 to Itaty and 
1 to Matta). In 9 of 12 patients (75%) an immuno- 
suppressive condition was found. 4 patients had 
AIDS with a CD4 cett count of tess than 100/mm 3. 
5 patients had other immunocompromising condi- 
tions (3 patients with a matignancy treated with 
chemo-/radiotherapy, 1 patient under treatment 
with steroids, 1 patient with diabetes). In 3 pa- 
tients no immunosuppression was found. 3 of the 4 
HIV-positive patients devetoped symptoms of inva- 
sive teishmaniasis before the introduction of highty 
active antiretrovirat therapy (1990-1998). After 
the year 2000 onty one patient was HIV-positive, 
whereas other tumors/immunosuppressant thera- 
pies were more common. 
